BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4268896)

  • 1. Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis.
    Niewiarowski S; Senyi AF; Gillies P
    J Clin Invest; 1973 Jul; 52(7):1647-59. PubMed ID: 4268896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmin inhibition of thrombin-induced platelet aggregation.
    Miller JL; Katz AJ; Feinstein MB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
    Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
    Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet interaction with polymerizing fibrin.
    Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
    J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of plasmin on rabbit platelets.
    Guccione MA; Kinlough-Rathbone RL; Packham MA; Harfenist EJ; Rand ML; Greenberg JP; Perry DW; Mustard JF
    Thromb Haemost; 1985 Feb; 53(1):8-14. PubMed ID: 3158094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
    Penny WF; Ware JA
    Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pyrimido-pyrimidine compounds on platelet function.
    Cucuianu MP; Nishizawa EE; Mustard JF
    J Lab Clin Med; 1971 Jun; 77(6):958-74. PubMed ID: 5559863
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditions influencing platelet lysis.
    Kinlough-Rathbone RL; Chahil AMAR ; Packham MA; Mustard JF
    Lab Invest; 1975 Mar; 32(3):352-8. PubMed ID: 1123914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prostaglandin E1 on platelet function in vitro and in vivo.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Br J Haematol; 1970 Nov; 19(5):559-71. PubMed ID: 4098211
    [No Abstract]   [Full Text] [Related]  

  • 14. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins.
    Rudd MA; George D; Amarante P; Vaughan DE; Loscalzo J
    Circ Res; 1990 Nov; 67(5):1175-81. PubMed ID: 2146037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
    Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet aggregation from interaction between washed platelets and purified thrombin, plasmin or trypsin (author's transl)].
    Matsuoka M; Watanabe T; Koike K; Sakuragawa N
    Rinsho Ketsueki; 1974 May; 15(5):519-23. PubMed ID: 4277899
    [No Abstract]   [Full Text] [Related]  

  • 17. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
    Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
    Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature dependence of plasmin-induced activation or inhibition of human platelets.
    Lu H; Soria C; Cramer EM; Soria J; Maclouf J; Perrot JY; Li H; Commin PL; Schumann F; Regnier O
    Blood; 1991 Mar; 77(5):996-1005. PubMed ID: 1825290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.